Hisamitsu Pharmaceutical Co., Inc.

久光製薬(株)

4530.T

Drug Manufacturers - Specialty & Generic

2026/01/16 Updated

Market Cap: $2.8B (¥445.2B)

Stock Price: $40.11 (¥6,356)

Exchange Rate: 1 USD = ¥158.48

Stock Price Chart

2026/01/16 Updated

23.59

PER (Price Earnings Ratio)

vs Industry Avg: +14.0

1.66

PBR (Price to Book Ratio)

vs Industry Avg: +0.4

1.38%

Dividend Yield

vs Industry Avg: -1.57%

Price Trend

2026/01/16 Updated

Short-term

5-Day MA

-0.87%

Near-term

25-Day MA

+31.77%

Mid-term

75-Day MA

+45.79%

Long-term

200-Day MA

+50.75%

Price & Trading Details

2026/01/16 Updated

PRICE

Previous Close ¥6,454

Open ¥6,450

High ¥6,480

Low ¥6,356

Close ¥6,356

TRADING

Volume 432,700

Average Volume 289,798

Turnover ¥28億

Min. Purchase ¥635,600

Analyst Recommendations 2 analysts

Updated 2026/01/11

Strong Buy

Buy

Hold

Sell

Strong Sell

Target Price (Mean)

¥4,250

Hold

¥4,300

High

¥4,250

Median

¥4,200

Low

-3% vs Current Price

This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/01/11

25.9%

Insider Holdings

36.1%

Institutional

38.1%

Public Float

Institutional Holders

Insider Holdings 25.9%

Institutional 36.1%

Public Float 38.1%

Major Holders

Updated 2026/01/11

Institution	Ownership	Shares	Change
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund	1.00%	750.7K	-7.21%
Goldman Sachs TRT-Goldman Sachs Intl Small Cap Insights Fd.	0.77%	579.5K	+1.20%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund	0.63%	472.5K	-6.38%
iShares Trust-iShares Core MSCI EAFE ETF	0.46%	342.1K	0.00%
iShares Trust-iShares MSCI EAFE Small-Cap ETF	0.24%	176.7K	+3.88%
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.	0.21%	156.3K	+57.56%

Dividend History 4Years Growth

Updated 2026/01/11

Dividend Yield

¥105

Annual Dividend

+20.0%

YoY Growth

35.5%

Payout Ratio

Year	Dividend	Change
2025	¥105	+20.0%
2024	¥88	+3.2%
2023	¥85	+0.6%
2022	¥84	+0.6%
2021	¥84	-

Financial Performance

2026/01/11 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

	2022	2023	2024	2025
Income Statement
Revenue	¥120,193M	¥128,330M	¥141,706M	¥156,006M
Gross Profit	¥70,067M	¥72,699M	¥78,970M	¥91,196M
Operating Income	¥9,337M	¥11,600M	¥13,167M	¥18,896M
Pretax Income	¥12,976M	¥16,128M	¥19,204M	¥28,710M
Net Income	¥9,658M	¥11,742M	¥13,969M	¥21,758M
EPS	¥118.84	¥147.88	¥181.42	¥295.57
Operating Margin	7.77%	9.04%	9.29%	12.11%
Balance Sheet
Total Assets	¥302,858M	¥313,917M	¥328,779M	¥343,068M
Total Equity	¥253,165M	¥256,362M	¥264,871M	¥276,822M
Total Liabilities	¥49,693M	¥57,555M	¥63,908M	¥66,246M
Cash	¥129,290M	¥122,154M	¥112,459M	¥114,518M
Interest-bearing Debt	¥2,460M	¥2,295M	¥2,100M	¥3,856M
Equity Ratio	83.59%	81.67%	80.56%	80.69%
D/E Ratio	0.01	0.01	0.01	0.01
Cash Flow
Operating CF	¥19,199M	¥12,727M	¥18,188M	¥18,765M
Investing CF	-¥13,060M	-¥23,868M	-¥2,512M	¥17,563M
Financing CF	-¥15,189M	-¥14,687M	-¥16,691M	-¥15,850M
Free CF	¥15,006M	¥4,819M	¥5,152M	¥4,991M
Efficiency
ROE	3.81%	4.58%	5.27%	7.86%
ROA	3.19%	3.74%	4.25%	6.34%